GLOWPIN
Live / Registered — Registered (as of 14 May 2024)
What this means for you
Registered since 14 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98018742
- Registration number
- 7389676
- Mark type
- Stylized text
- Filed
- 30 May 2023
- Published for opposition
- 28 Nov 2023
- Registered
- 14 May 2024
- Attorney of record
- LISA GREENWALD-SWIRE
Goods and services
- Class 010 — Medical apparatus: Medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus for facilitating the inhalation of pharmaceutical preparations; injection device for pharmaceuticals; anaesthetic apparatus; microdermabrasion apparatus for medical or therapeutic use; surgical apparatus and instruments; needles for medical purposes; medical fluid injectors; injection needles for medical use; surgical perforators; probes for medical purposes; acupuncture equipment; acupuncture needles; hypodermic syringes; medical surgical instruments for use in dermatoplasty; esthetic massage apparatus; massaging apparatus for personal use
Owner
- PDO Max, Inc., Liverpool, NY, US
- PDO Max, Inc., Liverpool, NY, US
- PDO Max, Inc., Liverpool, NY, US
Prosecution history
- 14 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Apr 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Apr 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Mar 2024 — USE AMENDMENT FILED
- 06 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
- 23 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Nov 2023 — PUBLISHED FOR OPPOSITION
- 08 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Oct 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Oct 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE